HomeCompareWWE vs MRK

WWE vs MRK: Dividend Comparison 2026

WWE yields 0.48% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $37.7K in total portfolio value
10 years
WWE
WWE
● Live price
0.48%
Share price
$100.65
Annual div
$0.48
5Y div CAGR
-15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$8.68
Full WWE calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — WWE vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodWWEMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, WWE + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
WWE pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

WWE
Annual income on $10K today (after 15% tax)
$40.54/yr
After 10yr DRIP, annual income (after tax)
$7.38/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, MRK beats the other by $8,589.34/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of WWE + MRK for your $10,000?

WWE: 50%MRK: 50%
100% MRK50/50100% WWE
Portfolio after 10yr
$38.9K
Annual income
$5,061.23/yr
Blended yield
13.03%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

WWE
Analyst Ratings
18
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$93.80
-6.8% upside vs current
Range: $79.00 — $120.00
Altman Z
10.4
Piotroski
8/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

WWE buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricWWEMRK
Forward yield0.48%2.81%
Annual dividend / share$0.48$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-15.8%32.7%
Portfolio after 10y$20.0K$57.7K
Annual income after 10y$8.68$10,113.78
Total dividends collected$210.00$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy
Analyst price target$93.80$128.54

Year-by-year: WWE vs MRK ($10,000, DRIP)

YearWWE PortfolioWWE Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$10,740$40.15$11,213$373.04$473.00MRK
2$11,526$33.94$12,667$512.06$1.1KMRK
3$12,361$28.66$14,439$708.14$2.1KMRK
4$13,251$24.19$16,640$988.16$3.4KMRK
5$14,199$20.40$19,432$1,394.07$5.2KMRK
6$15,210$17.20$23,057$1,992.90$7.8KMRK
7$16,289$14.50$27,889$2,894.79$11.6KMRK
8$17,442$12.22$34,518$4,286.29$17.1KMRK
9$18,673$10.30$43,912$6,494.35$25.2KMRK
10$19,989$8.68$57,714$10,113.78$37.7KMRK

WWE vs MRK: Complete Analysis 2026

WWEStock

World Wrestling Entertainment, Inc., an integrated media and entertainment company, engages in the sports entertainment business in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It operates through three segments: Media, Live Events, and Consumer Products. The Media segment engages in the production and monetization of long-form and short-form video content across various platforms, including WWE Network, broadcast and pay television, and digital and social media, as well as filmed entertainment. The Live Events segment is involved in the sale of tickets; provision of event services; and sale of travel packages related to its live events. The Consumer Products segment engages in merchandising of WWE branded products, such as video games, toys, apparel, and books through licensing arrangements and direct-to-consumer sales, as well as through e-commerce platforms. World Wrestling Entertainment, Inc. was founded in 1980 and is headquartered in Stamford, Connecticut.

Full WWE Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this WWE vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

WWE vs SCHDWWE vs JEPIWWE vs OWWE vs KOWWE vs MAINWWE vs JNJWWE vs ABBVWWE vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.